Hank Walther defends companies and individuals in complex criminal cases and conducts high-stakes internal investigations for leading companies around the globe. Hank defends companies and individuals that are facing criminal prosecution and civil liability from numerous government agencies and civil litigants, often in multiple countries. During his more than 20 years of practice, as both a defense attorney and federal prosecutor, Hank has led fraud and corruption investigations in more than 35 countries around the world.
Since joining Jones Day, Hank has conducted investigations for and defended industry-leading companies in the health care, technology, retail, extraction, engineering, and automotive industries. He has also successfully defended numerous senior corporate executives and government officials, recently obtaining a post-indictment dismissal of all charges against a corporate executive in an alleged $8 billion fraud scheme. Prior to joining Jones Day, Hank was a federal prosecutor in the Department of Justice's (DOJ) Criminal Division, Fraud Section, where he served as a line prosecutor, a supervisor in the Foreign Corrupt Practices Unit, and Chief of the Health Care Fraud Unit.
Hank has been recognized as a leading white collar lawyer by Chambers USA, Washingtonian magazine, The Legal 500, and Super Lawyers. Chambers has described Hank as "a go-to for complicated government matters," "a tremendous advocate," and "a trial animal" who has "instant credibility with DOJ."
Esperienze
Altre Pubblicazioni
- March 2019
FCPA Self-Disclosure Marches on in Year II of Trump Administration, Corporate Counsel Business Journal
- September 27, 2017
PLI's Storming the Gatekeepers: When Compliance Officers and In-House Lawyers Are at Risk 2017 - April 20, 2017
The State of the Union: FCPA Enforcement in a Trump Administration, 19th Annual New York Conference on the Foreign Corrupt Practices Act, American Conference Institute - January 12, 2017
The FCPA’s Jurisdictional Hooks – How Far Do They Reach, Who Can They Ensnare?, Eleventh Annual National Institute on Securities Fraud, American Bar Association - September 21, 2016
The French Anti-corruption Bill / Loi Sapin II – Crossed Views: France – United States - September 21, 2016
Sapin ll and International Anti-Corruption Developments - 21 septembre 2016
Loi Sapin II : Anti-corruption - Regards croisés France - Etats-Unis - February 9, 2016
First Deferred Prosecution in the UK, US Department of Justice agrees to close investigation - December 1, 2015
Anti-Corruption Congress - May 14-15, 2015
2015 Health Care Labor & Employment Symposium - September 26, 2013
Executive Roundtable Series - Responding to a Government Investigation: Defending the Company and Its People and Protecting Its Reputation - April 9-10, 2013
Jones Day 2013 Chicago Health Care Conference - May 8-9, 2012
FCPA and Anti-Corruption for the Life Sciences Industry 6th National Conference - April 19, 2012
Qui Tam Litigation: When Private Parties Pursue Claims for the Government - March 28, 2012
Health Care 2012: Issues and Answers for a Complex Industry - March 28, 2012
Healthcare 2012: Issues & Answers For A Complex Industry - March 15-16, 2012
Global Ethics Summit 2012, Thomson Reuters and the Ethisphere Institute - November 16, 2011
Medicare Fraud Strike Force: 2011 and Beyond, National Health Care Anti-Fraud Association, Annual Training Conference - November 15, 2011
Law Enforcement Strategies, Global Health Care Anti-Fraud Network, Global Health Care Fraud Prevention Summit - May 12, 2011
Government Enforcement Panel, American Bar Association, 21st National Institute on Health Care Fraud - January 25, 2011
Understanding the Department of Justice’s Enforcement Priorities: Steering Clear of Criminal and Civil Liability When Conducting Clinical Trials, American Conference Institute, Advanced Forum on Clinical Trials - January 24, 2011
Trends in Enforcement: Areas of Focus for State and Federal Prosecutors, Center for Business Intelligence, Pharmaceutical Compliance Conference - December 7, 2010
Enforcement and Compliance Roundtable, American Bar Association, Washington Healthcare Summit - November 17, 2010
Medicare Fraud Strike Force: 2010 and Beyond, National Health Care Anti-Fraud Association, Annual Training Conference - August 5, 2010
The Shift in Focus to Individuals in FCPA Prosecutions, American Bar Association, 2010 Annual Meeting - June 28, 2010
HEAT Anti-Fraud Initiative – Florida: Come for the Fraud and Stay for the HEAT, American Health Lawyer’s Association, 2010 Annual Meeting - June 23, 2010
Personal Liability: How the Shift Towards Individual Prosecution Will Affect You and Minimize FCPA Risks Before, During, and After M&A, Ethical Corporation 3rd Annual Global Anti-Corruption Summit USA - May 18, 2010
U.S. and International FCPA and Anti-Corruption Enforcement Priorities, American Conference Institute, FCPA and Anti-Corruption for Life Science Companies Conference - May 14, 2010
Trial Practice Demonstration: United States v. Valladares, American Bar Association, 20th National Institute on Health Care Fraud - March 23, 2010
Structuring Cost-Efficient Internal Investigations of Improper Payments, American Conference Institute, National Conference on the Foreign Corrupt Practices Act - February 23, 2010
When the Government Comes Knocking, Ethisphere Global Ethics Summit
- University of Maryland (J.D. with honors 2001; Executive Articles Editor, Maryland Law Review); American University (B.A. cum laude 1998)
- District of Columbia and Maryland
- U.S. Department of Justice, Criminal Division, Fraud Section: Chief, Health Care Fraud Unit (2010-2011); Assistant Chief, FCPA Unit (2008-2010); and Trial Attorney (2006-2008)
Chambers USA, White Collar Defense (2016-2022)
Washingtonian, Best Lawyers: Criminal Defense-White Collar (2019-2022)
Who's Who Legal: Investigations (2018-2022)
The Legal 500 United States, Corporate Investigations and White-Collar Criminal Defense (2019-2020)
Super Lawyers, White Collar Crime (2013-2022)
Assistant Attorney General's Award for Exceptional Service (2011)
U.S. Attorney General's Award for Distinguished Service (2008)
Prima di procedere all'invio, si prega di notare:
il contenuto del presente sito web è a scopo esclusivamente informativo e non può essere considerato un parere legale o altro tipo di consulenza professionale. L'invio o la ricezione della presente email non è atta ad instaurare alcun rapporto cliente/avvocato. Le informazioni inviate tramite questa funzione al nostro Studio non saranno coperte da vincolo di riservatezza o confidenzialità fintanto che non ci sia stato conferito e non sia stato da noi accettato un incarico professionale. Inviando il messaggio confermate di aver preso visione e accettato il contenuto di questa informativa.